| Antibody-mediated internalization of infectious HIV-1 virions differs among antibody isotypes and subclasses MZ Tay, P Liu, LTD Williams, MD McRaven, S Sawant, TC Gurley, TT Xu, ... PLoS pathogens 12 (8), e1005817, 2016 | 122 | 2016 |
| 3M-052, a synthetic TLR-7/8 agonist, induces durable HIV-1 envelope–specific plasma cells and humoral immunity in nonhuman primates SP Kasturi, MAU Rasheed, C Havenar-Daughton, M Pham, T Legere, ... Science immunology 5 (48), eabb1025, 2020 | 100 | 2020 |
| Antibody Fc effector functions and IgG3 associate with decreased HIV-1 risk SD Neidich, Y Fong, SS Li, DE Geraghty, BD Williamson, WC Young, ... The Journal of Clinical Investigation 129 (11), 4838-4849, 2019 | 100 | 2019 |
| Randomized, double-blind evaluation of late boost strategies for HIV-uninfected vaccine recipients in the RV144 HIV vaccine efficacy trial S Rerks-Ngarm, P Pitisuttithum, JL Excler, S Nitayaphan, J Kaewkungwal, ... The Journal of infectious diseases 215 (8), 1255-1263, 2017 | 72 | 2017 |
| Immune correlates of the Thai RV144 HIV vaccine regimen in South Africa GE Gray, Y Huang, N Grunenberg, F Laher, S Roux, E Andersen-Nissen, ... Science translational medicine 11 (510), eaax1880, 2019 | 58 | 2019 |
| HIV-1 envelope glycoproteins from diverse clades differentiate antibody responses and durability among vaccinees NL Yates, AC deCamp, BT Korber, HX Liao, C Irene, A Pinter, J Peacock, ... Journal of virology 92 (8), 10.1128/jvi. 01843-17, 2018 | 50 | 2018 |
| HIV-1 gp120 and modified vaccinia virus Ankara (MVA) gp140 boost immunogens increase immunogenicity of a DNA/MVA HIV-1 vaccine X Shen, R Basu, S Sawant, D Beaumont, SF Kwa, C LaBranche, ... Journal of virology 91 (24), 10.1128/jvi. 01077-17, 2017 | 31 | 2017 |
| Transcriptional and Posttranscriptional Regulation of Cytokine Gene Expression in HIV-1 Antigen-Specific CD8+ T Cells That Mediate Virus Inhibition TL Payne, J Blackinton, A Frisbee, J Pickeral, S Sawant, NA Vandergrift, ... Journal of virology 88 (17), 9514-9528, 2014 | 29 | 2014 |
| Phase 1 human immunodeficiency virus (HIV) vaccine trial to evaluate the safety and immunogenicity of HIV subtype C DNA and MF59-adjuvanted subtype C envelope protein MC Hosseinipour, C Innes, S Naidoo, P Mann, J Hutter, G Ramjee, ... Clinical Infectious Diseases 72 (1), 50-60, 2021 | 22 | 2021 |
| Computational analysis of antibody dynamics identifies recent HIV-1 infection KE Seaton, NA Vandergrift, AW Deal, W Rountree, J Bainbridge, E Grebe, ... JCI insight 2 (24), 2017 | 17 | 2017 |
| Analysis of the HIV Vaccine Trials Network 702 phase 2b–3 HIV-1 vaccine trial in South Africa assessing RV144 antibody and T-cell correlates of HIV-1 acquisition risk Z Moodie, O Dintwe, S Sawant, D Grove, Y Huang, H Janes, J Heptinstall, ... The Journal of infectious diseases 226 (2), 246-257, 2022 | 14 | 2022 |
| Monocyte-derived transcriptome signature indicates antibody-dependent cellular phagocytosis as a potential mechanism of vaccine-induced protection against HIV-1 S Shangguan, PK Ehrenberg, A Geretz, L Yum, G Kundu, K May, ... Elife 10, e69577, 2021 | 14 | 2021 |
| Effect of HIV-1 envelope cytoplasmic tail on adenovirus primed virus encoded virus-like particle immunizations AMC Andersson, E Ragonnaud, KE Seaton, S Sawant, A Folgori, ... Vaccine 34 (44), 5344-5351, 2016 | 14 | 2016 |
| Tissue memory B cell repertoire analysis after ALVAC/AIDSVAX B/E gp120 immunization of rhesus macaques K Luo, HX Liao, R Zhang, D Easterhoff, K Wiehe, TC Gurley, LC Armand, ... JCI insight 1 (20), 2016 | 13 | 2016 |
| HLA class II-restricted CD8+ T cells in HIV-1 virus controllers TE Nyanhete, AL Frisbee, T Bradley, WJ Faison, E Robins, T Payne, ... Scientific reports 9 (1), 10165, 2019 | 10 | 2019 |
| Salmonella Typhi Vi capsule prime-boost vaccination induces convergent and functional antibody responses LC Dahora, MK Verheul, KL Williams, C Jin, L Stockdale, G Cavet, ... Science immunology 6 (64), eabj1181, 2021 | 8 | 2021 |
| Safety and immunogenicity of Ad26-vectored HIV vaccine with mosaic immunogens and a novel mosaic envelope protein in HIV-uninfected adults: a phase 1/2a study DJ Stieh, DH Barouch, C Comeaux, M Sarnecki, KE Stephenson, ... The Journal of Infectious Diseases 227 (8), 939-950, 2023 | 7 | 2023 |
| Validation of a triplex pharmacokinetic assay for simultaneous quantitation of HIV-1 broadly neutralizing antibodies PGT121, PGDM1400, and VRC07-523-LS MS Wesley, KT Chiong, KE Seaton, CA Arocena, S Sawant, J Hare, ... Frontiers in Immunology 12, 709994, 2021 | 7 | 2021 |
| Meta-analysis of HIV-1 vaccine elicited mucosal antibodies in humans KE Seaton, A Deal, X Han, SS Li, A Clayton, J Heptinstall, A Duerr, ... npj Vaccines 6 (1), 56, 2021 | 7 | 2021 |
| Pharmacokinetic serum concentrations of VRC01 correlate with prevention of HIV-1 acquisition KE Seaton, Y Huang, S Karuna, JR Heptinstall, C Brackett, K Chiong, ... EBioMedicine 93, 2023 | 6 | 2023 |
